Views provided by UsageCounts
doi: 10.1186/s12879-021-06281-7 , 10.2139/ssrn.3697179 , 10.5281/zenodo.5913008 , 10.5281/zenodo.5913009
pmid: 34126960
pmc: PMC8200788
handle: 2434/850887 , 10281/328942 , 11365/1236683
doi: 10.1186/s12879-021-06281-7 , 10.2139/ssrn.3697179 , 10.5281/zenodo.5913008 , 10.5281/zenodo.5913009
pmid: 34126960
pmc: PMC8200788
handle: 2434/850887 , 10281/328942 , 11365/1236683
AbstractBackgroundVitamin D deficiency has been suggested to favor a poorer outcome of Coronavirus disease-19 (COVID-19). We aimed to assess if 25-hydroxyvitamin-D (25OHD) levels are associated with interleukin 6 (IL-6) levels and with disease severity and mortality in COVID-19.MethodsWe prospectively studied 103 in-patients admitted to a Northern-Italian hospital (age 66.1 ± 14.1 years, 70 males) for severely-symptomatic COVID-19. Fifty-two subjects with SARS-CoV-2 infection but mild COVID-19 symptoms (mildly-symptomatic COVID-19 patients) and 206 subjects without SARS-CoV-2 infection were controls. We measured 25OHD and IL-6 levels at admission and focused on respiratory outcome during hospitalization.ResultsSeverely-symptomatic COVID-19 patients had lower 25OHD levels (18.2 ± 11.4 ng/mL) than mildly-symptomatic COVID-19 patients and non-SARS-CoV-2-infected controls (30.3 ± 8.5 ng/mL and 25.4 ± 9.4 ng/mL, respectively,p < 0.0001 for both comparisons). 25OHD and IL-6 levels were respectively lower and higher in severely-symptomatic COVID-19 patients admitted to intensive care Unit [(ICU), 14.4 ± 8.6 ng/mL and 43.0 (19.0–56.0) pg/mL, respectively], than in those not requiring ICU admission [22.4 ± 1.4 ng/mL,p = 0.0001 and 16.0 (8.0–32.0) pg/mL,p = 0.0002, respectively]. Similar differences were found when comparing COVID-19 patients who died in hospital [13.2 ± 6.4 ng/mL and 45.0 (28.0–99.0) pg/mL] with survivors [19.3 ± 12.0 ng/mL,p = 0.035 and 21.0 (10.5–45.9) pg/mL,p = 0.018, respectively). 25OHD levels inversely correlated with: i) IL-6 levels (ρ − 0.284,p = 0.004); ii) the subsequent need of the ICU admission [relative risk, RR 0.99, 95% confidence interval (95%CI) 0.98–1.00,p = 0.011] regardless of age, gender, presence of at least 1 comorbidity among obesity, diabetes, arterial hypertension, creatinine, IL-6 and lactate dehydrogenase levels, neutrophil cells, lymphocytes and platelets count; iii) mortality (RR 0.97, 95%CI, 0.95–0.99, p = 0.011) regardless of age, gender, presence of diabetes, IL-6 and C-reactive protein and lactate dehydrogenase levels, neutrophil cells, lymphocytes and platelets count.ConclusionIn our COVID-19 patients, low 25OHD levels were inversely correlated with high IL-6 levels and were independent predictors of COVID-19 severity and mortality.
Adult, Male, Infectious and parasitic diseases, RC109-216, Comorbidity, COVID-19; Interleukin-6; Mortality; Vitamin D; Adult; Aged; Aged, 80 and over; COVID-19; Calcifediol; Comorbidity; Diabetes Mellitus; Female; Humans; Hypertension; Intensive Care Units; Interleukin-6; Italy; Male; Middle Aged; Obesity; Patient Admission; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Vitamin D; Vitamin D Deficiency; Vitamins; Severity of Illness Index, COVID-19; Interleukin-6; Mortality; Vitamin D;, Patient Admission, COVID-19; Interleukin-6; Mortality; Vitamin D, Diabetes Mellitus, Humans, Obesity, Prospective Studies, Vitamin D, Mortality, Aged, Calcifediol, Aged, 80 and over, Interleukin-6, Reverse Transcriptase Polymerase Chain Reaction, SARS-CoV-2, COVID-19, Middle Aged, Intensive Care Units, Italy, Hypertension, Female, COVID-19; Interleukin-6; Mortality; Vitamin D., Research Article
Adult, Male, Infectious and parasitic diseases, RC109-216, Comorbidity, COVID-19; Interleukin-6; Mortality; Vitamin D; Adult; Aged; Aged, 80 and over; COVID-19; Calcifediol; Comorbidity; Diabetes Mellitus; Female; Humans; Hypertension; Intensive Care Units; Interleukin-6; Italy; Male; Middle Aged; Obesity; Patient Admission; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Vitamin D; Vitamin D Deficiency; Vitamins; Severity of Illness Index, COVID-19; Interleukin-6; Mortality; Vitamin D;, Patient Admission, COVID-19; Interleukin-6; Mortality; Vitamin D, Diabetes Mellitus, Humans, Obesity, Prospective Studies, Vitamin D, Mortality, Aged, Calcifediol, Aged, 80 and over, Interleukin-6, Reverse Transcriptase Polymerase Chain Reaction, SARS-CoV-2, COVID-19, Middle Aged, Intensive Care Units, Italy, Hypertension, Female, COVID-19; Interleukin-6; Mortality; Vitamin D., Research Article
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 93 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
| views | 2 |

Views provided by UsageCounts